Recent Drug Discovery Research for November 2024
Secondary (Hypogonadotropic) Hypogonadism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Diabetic Foot Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Cardiovascular
| Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Obesity, Drug Discovery
| Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Arthritis, Psoriasis, Drug Discovery
| Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Arthritis, Drug Discovery
| Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery
| Anaplastic Astrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, CNS/Neurology
| Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Hepatitis, Drug Discovery
| Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery
| Cellular Immunotherapy Market Report 2021-2031
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Anti-obesity Drugs Market Report 2021-2031
Topics: Obesity, Diet Food & Weight Loss, Over-the-Counter Drugs, Prescription Drugs, Drug Discovery
Regions: Global
| RNA Based Therapeutics and Vaccines Market Report 2022-2032
Topics: Drug Development, Gene Editing, Vaccines, Drug Discovery
| HIV and HBV Therapies Market Report 2022-2032
Topics: AIDS, HIV & STDs, Manufacturing, Packaging & Detailing, Prescription Drugs, Drug Discovery
| Wounds (Dermatology) - Drugs in Development, 2021
Topics: Wound Care, Research & Development, Prescription Drugs, Drug Discovery, Dermatology
| Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Respiratory Devices, Drug Discovery, Infectious Diseases, Respiratory/Pulmonary
| The 2023-2028 World Outlook for Glaucoma Therapeutics
Topics: Ophthalmic Devices, Drug Discovery, Ophthalmology
Regions: Global
| 2022 Global: Drug Discovery Services - Innovative Markets Forecast (2028) report
Topics: Drug Development, Drug Discovery
Regions: Global
| 2022 Global: Osteoarthritis Therapeutics - Innovative Markets Forecast (2028) report
Topics: Arthritis, Osteoporosis, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Acromegaly Treatments
Topics: Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
Regions: Global
| The 2023-2028 World Outlook for Albumin Plasma Protein Therapeutics
Topics: Proteomics, Antibody Technologies, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
Topics: Drug Discovery, Cardiovascular
Regions: Global
| The 2023-2028 World Outlook for Alkylating Gynaecological Cancer Drugs
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| The 2023-2028 World Outlook for Allergy Diagnostics and Therapeutics
Topics: Allergic Conditions, Drug Discovery, Allergy/Immunology
Regions: Global
| The 2023-2028 World Outlook for Alzheimer's Disease Therapeutics and Diagnostics
Topics: Alzheimer's Disease, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Angina Pectoris Antiplatelet Drugs
Topics: Prescription Drugs, Drug Discovery, Cardiovascular
Regions: Global
| The 2023-2028 World Outlook for Angina Pectoris Drugs
Topics: Prescription Drugs, Drug Discovery, Cardiovascular
Regions: Global
| The 2023-2028 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics
Topics: Autoimmune, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Anti-Inflammatory Therapeutics
Topics: Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Anti-Migraine Drugs
Topics: Pain, Prescription Drugs, Drug Discovery, CNS/Neurology
Regions: Global
| The 2023-2028 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments
Topics: Manufacturing, Packaging & Detailing, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Antiviral Drugs
Topics: Drug Development, Prescription Drugs, Drug Discovery, Infectious Diseases
Regions: Global
| The 2023-2028 World Outlook for Anxiety Disorder Therapeutics
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, Drug Discovery, Behavioral Health
Regions: Global
| The 2023-2028 World Outlook for Artificial Intelligence in Medicines
Topics: Internet of Things IoT, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Autism Spectrum Disorder Therapeutics
Topics: Drug Discovery, CNS/Neurology, Behavioral Health
Regions: Global
| The 2023-2028 World Outlook for Autism Therapies
Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
Regions: Global
| The 2023-2028 World Outlook for Basal Cell Carcinoma Treatments
Topics: Cancer Treatment, Research & Development, Drug Discovery, Oncology/Hematology
Regions: Global
| The 2023-2028 World Outlook for Bio-Simulation Technologies
Topics: Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Biosimulation Technology Software
Topics: Drug Development, Drug Discovery
Regions: Global
|
Prev | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
